NRT Smoking Cessation Aids in Canada
Euromonitor International's NRT Smoking Cessation Aids in Canada market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 31 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
NRT gum; NRT inhalators; NRT lozenges; NRT patches; Other NRT
Table of contents
NRT SMOKING CESSATION AIDS IN CANADA : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 1 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 2 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 3 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 4 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 5 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 6 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 7 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 8 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - CANADA
APOTEX INC - OTC HEALTHCARE - CANADA
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Apotex Inc: Key Facts
COMPANY BACKGROUND
COMPETITIVE POSITIONING
CE JAMIESON & CO LTD - OTC HEALTHCARE - CANADA
STRATEGIC DIRECTION
KEY FACTS
Summary 2 CE Jamieson & Co Ltd: Key Facts
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 3 CE Jamieson & Co Ltd: Competitive Position 2008
CV TECHNOLOGIES INC - OTC HEALTHCARE - CANADA
STRATEGIC DIRECTION
KEY FACTS
Summary 4 CV Technologies Inc: Key Facts
Summary 5 CV Technologies Inc: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 6 CV Technologies Inc: Competitive Position 2008
PHARMASCIENCE INC - OTC HEALTHCARE - CANADA
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Pharmascience Inc: Key Facts
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 8 Pharmascience Inc: Competitive Position 2008
SWISS HERBAL REMEDIES LTD - OTC HEALTHCARE - CANADA
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Swiss Herbal Remedies Ltd: Key Facts
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 10 Swiss Herbal Remedies Ltd: Competitive Position 2008
OTC HEALTHCARE IN CANADA
EXECUTIVE SUMMARY
Quiet year and slow growth of mature market
Ageing population remains the principal driver of sales
Private label gained ground
Chained parapharmacies/drugstores lead OTC distribution
Slow growth is expected in the coming years
KEY TRENDS AND DEVELOPMENTS
Ageing population and tendency to self-medicate remain primary growth drivers
Private label is gaining ground as economy weakens
Most natural remedies are struggling
Foreign-based manufacturers lead sales
Large drugstore chains still prevail in distribution of OTC healthcare
MARKET INDICATORS
Table 9 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 10 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 11 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 12 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 13 OTC Healthcare Company Shares by Value 2004-2008
Table 14 OTC Healthcare Brand Shares by Value 2005-2008
Table 15 Penetration of Private Label by Sector 2003-2008
Table 16 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 17 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 18 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 19 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Self-medication and Preventive Medicine
Generics
Switches
Summary 11 OTC Healthcare Switches 2005-2008
DEFINITIONS
Summary 12 Research Sources